COVID-19’s impact on in-person work and global value chains may slow down innovation, too.
Carl Benedikt Frey
MIT SMR’s Latest Global Business Insights
Sarah H. Bana et al.
Karen Dillon et al.
More Global Business Articles from MIT SMR
Pharma’s existing model may be a liability in the race to develop drugs and vaccines to combat COVID-19.
Markus Scholz and N. Craig Smith
The business climate remains unpredictable, but supply chain leaders should plot their comebacks.
What managers can learn from the coronavirus outbreak.
Howard Yu and Mark J. Greeven
The kinds of challenges we face with the coronavirus point to permanent changes we must make.